ACM
TLSA icon

Altium Capital Management’s Tiziana Life Sciences TLSA Stock Holding History

Altium Capital Management’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,077,883
Closed -$2.18M – 140
2020
Q4 		$2.18M Buy
+1,077,883
New +$3.41M 0.81% 52

Other funds holding TLSA

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Altium Capital Management's TLSA Position: Q1 2021 in Review

Altium Capital Management sold out of Tiziana Life Sciences (TLSA) in Q1 2021, closing a stake of 1,077,883 shares — an estimated $2.18M sold.

Altium Capital Management first reported a position in TLSA in Q4 2020 and held it in 1 quarter. The position peaked at $2.18M in Q4 2020. 23 funds tracked by Wall St. Rank hold TLSA as of Q1 2021.

  • Altium Capital Management reported no remaining Tiziana Life Sciences position as of Q1 2021 after selling out during the quarter.
  • Altium Capital Management sold 1,077,883 Tiziana Life Sciences shares in Q1 2021, an estimated $2.18M.
  • Altium Capital Management first reported a position in Tiziana Life Sciences in Q4 2020 and held it in 1 quarter.
  • Altium Capital Management's Tiziana Life Sciences position peaked at $2.18M in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2021.

Based on Altium Capital Management's 13F filing for Q1 2021, filed 6 May 2021.